In addition, 5-HT exhibits a distinctive form of neuroplasticity that encompasses synaptic plasticity
The FDA's classification indicates the need for more rigorous investigation, impacting the availability and distribution of BPC 157
doi: 10.1007/s11738-013-1389-4 55 Otulak-KozieK.KozieE.BujarskiJ
Additional information DISCLOSURE/CONFLICT OF INTEREST Michael Berk declares that over the past three years, he has received compensation from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Norvatis, Mayne Pharma and Servier